CMO Letter to Reduce Unnecessary Antibiotic Prescribing March 2018

NCT03582072 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

4796

Enrollment

OTHER_GOV

Sponsor class

Conditions

Prescribing, Off-Label

Interventions

BEHAVIORAL: letter from the CMO

Sponsor

Public Health England